TIMES24H – International Breaking NewsTIMES24H – International Breaking News
    Facebook Twitter Instagram
    TIMES24H – International Breaking News TIMES24H – International Breaking News
    • Breaking News
      • COVID-19
      • Vietnam
      • Asia
      • World
      • Video
    • Business
    • Life
      • Lifestyle
      • Recipes
      • Fashion
    • Opinion
    • Sport
    • Tech
      • Gadgets
    • Podcast
    Facebook Twitter Instagram
    TIMES24H – International Breaking NewsTIMES24H – International Breaking News
    Home»Breaking News»European health regulator confirms ‘casual link’ between blood clot and AstraZeneca vaccine
    Breaking News

    European health regulator confirms ‘casual link’ between blood clot and AstraZeneca vaccine

    Mike HarrisonMike HarrisonApril 6, 2021No Comments5 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    European health regulator confirms ‘casual link’ between blood clot and AstraZeneca vaccine
    Share
    Facebook Twitter LinkedIn Pinterest Email
    0
    (0)

    As the agency gears up for a detailed statement in the coming week, it said the benefits of taking the shot outweigh the risks.

    A top official at the European Medicines Agency says there’s a causal link between AstraZeneca’s coronavirus vaccine and rare blood clots, but that it’s unclear what the connection is and that the benefits of taking the shot still outweigh the risks of getting COVID-19.

    Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome’s Il Messaggero newspaper on Tuesday that the European Union’s medicines regulator is preparing to make a more definitive statement on the topic this week.

    Asked about Mr. Cavaleri’s comments, the EMA press office said its evaluation “has not yet reached a conclusion and the review is currently ongoing.” It said it planned a press conference as soon as the review is finalised, possibly Wednesday or Thursday.

    Based on the evidence so far, Mr. Cavaleri said there’s a clear association between the AstraZeneca vaccine and the dozens of rare blood clots that have been reported worldwide amid the tens of millions of AstraZeneca shots that have been given out.

    “It is becoming more and more difficult to affirm that there isn’t a cause-and-effect relationship between AstraZeneca vaccines and the very rare cases of blood clots associated with a low level of platelets,” Mr. Cavaleri was quoted as saying.

    AstraZeneca did not immediately respond to a request for comment. Late in the day, however, the pharmaceutical company and Oxford University, which developed the vaccine, announced they were pausing the trial of their jabs in children while British regulators investigate the potential blood clot link in adults.

    Additional information awaited

    “Whilst there are no safety concerns in the pediatric clinical trial, we await additional information” from the British regulator, an Oxford spokesperson said in a statement.

    In Geneva, the World Health Organisation said its experts were also evaluating a possible link between the AstraZeneca vaccine and rare blood clots — and that it might have a “fresh, conclusive assessment” before Thursday.

    In March, more than a dozen countries, including Germany, suspended using AstraZeneca over the blood clot issue. Most EU nations restarted on March 19 — some with age restrictions — after the EMA said the benefits of the vaccine outweighed the risks of not inoculating people against COVID-19. At the time, the EMA recommended the vaccine’s leaflet be updated with information about the rare clots.

    Any further doubts about the AstraZeneca vaccine would be a setback for the shot, which is critical to Europe’s immunisation campaign and a linchpin in the global strategy to get vaccines to poorer countries. The AstraZeneca vaccine is cheaper and easier to use than rival vaccines from Pfizer and Moderna and has been endorsed for use in over 50 countries, including by the 27-nation EU and the World Health Organisation. U.S. authorities are still evaluating the vaccine.

    Further study needed

    Mr. Cavaleri said while EMA was prepared to declare a link, further study was still needed to understand why and how the phenomenon occurs.

    He said the rare blood clots, including some in the brain, coupled with a low level of blood platelets that may make people at risk of serious bleeding, “seem to be the key event to study further.” Mr. Cavaleri promised more details soon, adding: “In the coming hours, we will say that the link is there, how this happens we still haven’t figured out.”

    Mr. Cavaleri said the biological mechanism for how the vaccine might be causing the rare clots was still unknown and if it was linked to how the shot is made, other vaccines with similar technologies might also need to be evaluated.

    He stressed the risk-benefit analysis remained positive for the AstraZeneca jab, even for young women who appear to be more affected by the clots.

    “Let’s not forget that young women also end up in intensive care with COVID. So we need to do very meticulous work to understand if the risk-benefit analysis remains for all ages,” he was quoted as saying.

    He ruled out a preventive therapy to address the rare blood clots, saying there is still too much unknown about the phenomenon.

    Even after the March 19 restart, the Dutch and German governments suspended the jabs for people under 60 and some Europeans have been shying away from getting a shot.

    Romanians give it a miss

    Romania’s national vaccination committee’s chief, Valeriu Gheorghita, said on Tuesday that since March, 2,07,000 people in Romania had canceled their AstraZeneca vaccine appointments and another 92,000 simply didn’t show up.

    “It is a high percentage, a third of people scheduled who did not show up,” Mr. Gheorghita told reporters.

    British Prime Minister Boris Johnson declined to be drawn directly into the latest warnings about the vaccine but urged people to look at the advice from Britain’s independent Medicines and Healthcare Regulatory Agency.

    “Their advice to people is to keep going out there, get your jab, get your second jab,” he said during a visit Tuesday to an AstraZeneca facility in Macclesfield, in northwest England.

    Last week, Britain’s MHRA said seven people had died in the U.K. due to blood clots after getting the AstraZeneca jab. It said it wasn’t clear if the shots are causing the clot and that it was undertaking a “rigorous review” into the reports. The agency said it had identified 30 blood clot cases out of 18.1 million AstraZeneca jabs given by March 24.

    Adam Finn, a professor of pediatrics at the University of Bristol, said the latest surge of COVID-19 cases that is filling up hospitals across Europe should prompt people to get vaccinated as soon as possible.

    “If you are currently being offered a dose of Oxford-AstraZeneca vaccine, your chances of remaining alive and well will go up if you take the vaccine and will go down if you don’t,” he said.

    Source

    How useful was this post?

    Click on a star to rate it!

    Average rating 0 / 5. Vote count: 0

    No votes so far! Be the first to rate this post.

    As you found this post useful...

    Follow TIMES 24H on social media!

    We are sorry that this post was not useful for you!

    Let us improve this post!

    Tell us how we can improve this post?

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Gojek Vietnam hit the milestone of 200.000 driver partners

    April 20, 2021

    Lotteria Vietnam denies information to withdraw food business

    April 20, 2021

    Nutifood launches Nutifood Nutrition Research Institute in Sweden (NNRIS)

    April 15, 2021

    Leave A Reply Cancel Reply

    Latest

    Gojek Vietnam hit the milestone of 200.000 driver partners

    April 20, 2021

    Lotteria Vietnam denies information to withdraw food business

    April 20, 2021

    Xiaomi clarifies how Mi Mix Fold has improved warmth dissemination among foldables

    April 16, 2021

    Nutifood launches Nutifood Nutrition Research Institute in Sweden (NNRIS)

    April 15, 2021
    DMCA.com Protection Status
    Facebook Twitter Instagram Pinterest
    © 2021 TIMES24H. Regn. No. 0316487598. All rights reserved

    Type above and press Enter to search. Press Esc to cancel.

    TIMES 24H use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled

    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

    Non-necessary

    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

    SAVE & ACCEPT
    en English
    ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanishvi Vietnamese
    Go to mobile version